Medulloblastoma is a cancerous brain tumor that begins in the cerebellum, a region at the back of the brain that controls balance and movement. Though it can affect anyone, this aggressive tumor most commonly strikes young children, making it the leading cancerous brain tumor in pediatric patients.

Epidemiology

Medulloblastoma represents a significant challenge in pediatric oncology, despite being relatively uncommon in the general population. Each year, approximately 437 children and adults in the United States receive this diagnosis, making it a rare condition overall. However, when focusing specifically on childhood brain cancers, medulloblastoma emerges as the most frequent type of cancerous brain tumor, accounting for nearly 20 percent of all pediatric brain tumors.^[1][2][3]

The disease shows clear patterns in who it affects most. Children between the ages of 5 and 9 face the highest risk, though the tumor can develop at any age from infancy through adulthood. Most cases occur in children and teenagers under 16 years old. When medulloblastoma does appear in adults, which is far less common, it typically strikes people between 20 and 45 years of age.^[2][4]

Gender also plays a role in risk patterns. Boys develop medulloblastoma more frequently than girls, though researchers have not fully explained why this difference exists. In the United Kingdom, roughly 52 children are diagnosed with medulloblastoma annually, showing that the condition affects pediatric populations across different countries at similar rates.^[4]

Causes

Scientists have not identified a clear cause for most cases of medulloblastoma. The tumor develops when cells in the cerebellum—the brain region responsible for coordination and balance—begin growing abnormally and out of control. These cells are thought to be immature or embryonic cells that failed to develop properly. Rather than maturing into normal brain tissue, they continue multiplying, forming a mass that doctors call a tumor.^[1][5]

Unlike infectious diseases, medulloblastoma cannot be transmitted from person to person. It is not contagious and does not spread through contact or proximity to someone who has the condition. Some early studies explored possible connections between maternal diet or blood disorders during pregnancy and the development of medulloblastoma in children, but these links remain unproven. Other research has looked at potential associations with viral infections, such as early childhood exposure to certain viruses, but again, no definitive cause-and-effect relationship has been established.^[3]

What researchers do understand is that medulloblastoma is fundamentally a genetic disease. This means changes to genes that control how cells function and divide lead to the tumor’s formation. These genetic mutations cause cells to grow and spread in ways they should not. In the vast majority of cases, these genetic changes occur randomly during a person’s lifetime and are not inherited from parents.^[5]

Risk Factors

While most children who develop medulloblastoma have no identifiable risk factors, certain inherited genetic conditions significantly increase the likelihood of developing this tumor. Less than 5 percent of all medulloblastoma cases are linked to these hereditary syndromes, but for families affected by them, the risk becomes much more tangible.^[2][4]

Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, is one such condition. People with Gorlin syndrome face about a 5 percent chance of developing medulloblastoma. This hereditary condition also increases the risk of skin cancers and other health problems. Another syndrome, called Turcot syndrome, combines colon cancer with central nervous system tumors, including medulloblastoma.^[1][2]

Li-Fraumeni syndrome represents another important risk factor. This inherited condition dramatically raises the risk of multiple cancer types, including various brain cancers, breast cancer, bone and soft tissue cancers, and leukemia. People with this syndrome carry mutations in genes that normally help repair damaged genetic material, leaving cells more vulnerable to becoming cancerous.^[2]

Mutations in genes called BRCA1 and BRCA2 also elevate risk. These genes typically help fix damaged DNA in cells throughout the body. When inherited variants of these genes are passed down through families, the risk for many types of cancer increases, not just medulloblastoma. Additionally, a condition called Fanconi anemia, which affects the body’s ability to repair DNA damage, has been associated with higher medulloblastoma risk.^[2][3]

Symptoms

The symptoms of medulloblastoma develop because the tumor grows in a confined space inside the skull. As the mass expands, it puts pressure on surrounding brain tissue and can block the normal flow of cerebrospinal fluid—a clear liquid that cushions and protects the brain and spinal cord. This blockage leads to a condition called hydrocephalus, where fluid builds up inside the brain, creating increased pressure inside the skull.^[1][5]

Headaches are among the most common symptoms, particularly occurring in the morning or upon waking. These headaches result from the increased pressure inside the skull. Many children also experience nausea and vomiting, which often provides temporary relief from the head pain. Parents may notice their child vomiting repeatedly, especially in the morning, and mistakenly think it represents a stomach problem or migraine rather than a brain condition.^[2][7]

Because the cerebellum controls balance and coordination, damage to this area creates movement problems. Children may stumble frequently, have difficulty walking steadily, or fall backward often. They might struggle with tasks requiring fine motor control, such as writing or buttoning clothes. Some develop double vision or have trouble with their eyesight. A head tilt or difficulty moving the eyes in certain directions can also occur.^[1][6]

Tiredness and lethargy often accompany these other symptoms. Young children who cannot clearly express what they feel may become unusually irritable or fractious. Parents might notice it takes longer to settle their child or that the child interacts less with siblings and family members than usual. Changes in personality or behavior can signal something is wrong, even if the child cannot articulate specific complaints.^[4][6]

In infants, doctors or parents may notice the soft spot on top of the skull, called the fontanelle, appears swollen or bulging. The baby’s head circumference may increase more rapidly than normal. These signs indicate fluid is building up inside the brain. If medulloblastoma has spread to the spinal cord, additional symptoms can include back pain, weakness in the legs, difficulty walking, and problems controlling urination or bowel movements.^[4][5]

The duration and severity of symptoms vary considerably. Some families notice changes developing over just a few weeks, while others observe a gradual progression over several months before seeking medical attention. Many of these symptoms resemble common, less serious childhood illnesses, which can delay diagnosis. Any parent concerned about persistent or worsening symptoms should consult their child’s doctor without delay.^[4]

Prevention

Currently, there are no known ways to prevent medulloblastoma. Because scientists have not identified clear environmental causes or lifestyle factors that trigger the disease, no specific prevention strategies exist. The tumor typically develops due to random genetic changes that occur during a person’s life, changes that cannot be predicted or avoided through diet, exercise, or other health behaviors.^[1][5]

For families with known genetic syndromes that increase medulloblastoma risk, genetic counseling and testing can provide important information. Understanding whether family members carry genetic mutations associated with conditions like Li-Fraumeni syndrome or Gorlin syndrome helps doctors monitor at-risk individuals more closely. However, even with enhanced surveillance, there is no way to prevent tumor formation in people who carry these genetic variants.^[2]

The most important action parents can take is recognizing symptoms early and seeking prompt medical evaluation when concerning signs appear. Earlier diagnosis often leads to better treatment outcomes, even though the disease itself cannot be prevented. Parents should not blame themselves or search for things they did wrong, as medulloblastoma develops through no fault of the family or patient.^[4]

Pathophysiology

Understanding what happens inside the body when medulloblastoma develops requires looking at where the tumor forms and how it behaves. The cerebellum, located at the back lower portion of the brain, normally coordinates muscle movements, maintains balance, and helps with posture. Medulloblastomas begin when cells in this region—believed to be remnant fetal cells that remained after birth—fail to mature properly and instead multiply uncontrollably.^[5][7]

These tumor cells are classified as embryonal neuroepithelial tumors, meaning they arise from primitive nerve tissue that should have developed into mature brain cells. Instead, they remain in an immature state and continue dividing rapidly. Under a microscope, medulloblastoma tissue appears densely packed with small, dark-staining cells that have very little surrounding material. The cells divide actively, creating many new cells quickly, which explains why these tumors grow so fast.^[3][5]

All medulloblastomas are classified as grade 4 tumors, also written as grade IV. This designation means they are malignant—cancerous—and fast-growing. The grading system helps doctors understand how aggressive the tumor is and guides treatment decisions. Medulloblastomas are particularly concerning because they have a strong tendency to spread beyond their original location.^[5]

Unlike many brain tumors that remain localized, medulloblastomas frequently spread through the cerebrospinal fluid that bathes the brain and spinal cord. Cancer cells can break away from the main tumor mass and float through this fluid, settling in other areas of the central nervous system. When the disease spreads down the spinal column, doctors call this “drop metastasis.” About 30 out of every 100 children—roughly 30 percent—already have cancer that has spread by the time doctors make the diagnosis.^[1][4][5]

The tumor’s location in the posterior fossa—the lower back part of the skull—creates specific mechanical problems. This area contains pathways through which cerebrospinal fluid normally flows. When a tumor grows here, it can block these channels, preventing fluid from circulating properly. The trapped fluid accumulates, creating increased pressure throughout the brain. This pressure causes many of the symptoms patients experience, from headaches to vomiting to problems with vision and balance.^[5][9]

Scientists have identified at least four distinct molecular subgroups of medulloblastoma based on genetic features within the tumor cells. These subgroups are named WNT-activated, SHH-activated, Group 3, and Group 4. Each subgroup has different genetic characteristics, grows in slightly different patterns, and responds differently to treatment. This molecular classification helps doctors better predict how aggressive a particular tumor will be and tailor treatment accordingly.^[5]

In rare cases, medulloblastoma can spread outside the central nervous system to other parts of the body, such as bones, lungs, or lymph nodes. This happens more commonly when the disease returns after initial treatment or in adult patients. However, the vast majority of medulloblastoma’s spread remains confined to the brain and spinal cord.^[5][7]